1. Pink Sheet

US FDA’s Narrow Path For Imports: Beware The 'SIP'-pery Slope

 
• By Michael McCaughan

Newly proposed pathway to allow states to pursue wholesale importation of drugs from Canada is extremely narrow and restrictive, at least in draft form. It is still a terrible precedent for industry – one that can be easily expanded if it takes effect.

A man is landing down from a sloppy and slippery slope. Stock photograph of a person without face landing down from rocky slippery slope.

It is no coincidence that US Health & Human Services Secretary Alex Azar was in Florida on 18 December to unveil a new proposed rule to permit wholesale importation of drugs from Canada.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Pricing Debate

More from Market Access